Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results
J. Coward, M. Barve, G. Kichenadasse, K. Moore, P. Harnett, D. Berg, J. Garner, D. Dizon
Cancers